What is the recommended dosage of lisinopril (Angiotensin-Converting Enzyme inhibitor) for a patient with hypertension or heart failure, considering factors such as age, Impaired renal function, and other comorbidities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Dispensing Quantity and Dosing

For hypertension, dispense a 30-day supply of 10-20 mg tablets (30 tablets for once-daily dosing), with the standard starting dose being 10 mg once daily and usual maintenance range of 20-40 mg daily. 1

Standard Dispensing Quantities by Indication

Hypertension

  • Initial prescription: Dispense 30 tablets of 10 mg strength for once-daily dosing 1
  • Maintenance prescription: Dispense 30 tablets of 20 mg strength (most common maintenance dose) or 40 mg strength depending on titration 1
  • The FDA-approved dosing range is 20-40 mg daily as a single dose, though doses up to 80 mg have been used 1

Heart Failure

  • Initial prescription: Dispense 30 tablets of 5 mg strength (or 2.5 mg if patient has hyponatremia with serum sodium <130 mEq/L) 1
  • Target maintenance prescription: Dispense 30 tablets of 30-35 mg strength for optimal outcomes 2, 3
  • The European Society of Cardiology recommends targeting 30-35 mg once daily, as high-dose lisinopril (32.5-35 mg daily) reduces death or hospitalization by 12% and heart failure hospitalizations by 24% compared to low doses 4, 2, 5
  • Maximum FDA-approved dose is 40 mg daily 1

Post-Myocardial Infarction

  • Initial prescription: Dispense 30 tablets of 5 mg strength (or 2.5 mg if systolic BP ≤120 mmHg) 1
  • Maintenance prescription: Dispense 30 tablets of 10 mg strength for once-daily dosing 1
  • Therapy should continue for at least 6 weeks 1

Dose Adjustments for Renal Impairment

Moderate Renal Impairment (CrCl 10-30 mL/min)

  • Initial prescription: Dispense 30 tablets of 5 mg strength for hypertension, or 2.5 mg for heart failure 1
  • Reduce initial dose to half the usual recommended dose 1
  • The European Heart Journal recommends dose adaptation when CrCl <30 mL/min, with initial dose of 1.25 mg daily and maximum of 5 mg/day 4

Severe Renal Impairment (CrCl <10 mL/min or Hemodialysis)

  • Initial prescription: Dispense 30 tablets of 2.5 mg strength 1
  • Start at 2.5 mg once daily and titrate as tolerated 1, 6, 7

Titration Schedule and Monitoring

Dose Escalation Protocol

  • Increase doses at minimum 2-week intervals to allow full assessment of blood pressure response 4, 2, 3
  • Double the dose at each titration step until target or maximum tolerated dose is reached 4
  • For heart failure patients, aim for at least 50% of target dose (minimum 10 mg daily) for optimal clinical benefit 2

Monitoring Requirements

  • Check blood pressure, serum creatinine, and potassium within 5-7 days after initiation or any dose increase 2, 3
  • Repeat monitoring at 3 months, then every 6 months during maintenance therapy 2, 3
  • An increase in creatinine up to 50% above baseline is acceptable during titration 2, 3

Critical Prescribing Considerations

When to Use Lower Starting Doses

  • Volume depletion or concurrent diuretic use: Start with 5 mg daily for hypertension 1
  • Hyponatremia (sodium <130 mEq/L): Start with 2.5 mg daily for heart failure 1
  • Low systolic BP (≤120 mmHg) post-MI: Start with 2.5 mg daily 1
  • Elderly patients or those with renal impairment: Consider starting at lower doses 8

Important Pitfalls to Avoid

  • Asymptomatic hypotension does not require dose reduction—only symptomatic hypotension warrants intervention 4, 3
  • Avoid NSAIDs and COX-2 inhibitors as they reduce ACE inhibitor efficacy and worsen renal function 3
  • Avoid potassium-sparing diuretics during initiation due to hyperkalemia risk 3
  • Some ACE inhibitor is better than no ACE inhibitor—use the highest tolerated dose even if target cannot be reached 4, 2

Pediatric Dosing (Age ≥6 years with GFR >30 mL/min/1.73m²)

  • Start at 0.07 mg/kg once daily (maximum 5 mg) 1
  • Titrate to maximum of 0.61 mg/kg once daily (not exceeding 40 mg) 1
  • Calculate total monthly tablets needed based on weight-based dosing

Practical Dispensing Recommendations

For a typical new hypertension patient: Dispense #30 tablets of 10 mg strength with instructions for once-daily dosing, with refills allowing titration to 20-40 mg daily 1

For a heart failure patient: Dispense #30 tablets of 5 mg strength initially, with plan to titrate toward 30-35 mg daily over subsequent months for optimal mortality benefit 2, 5

References

Guideline

Lisinopril Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Lisinopril Dosing and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lisinopril in hypertension associated with renal impairment.

Journal of cardiovascular pharmacology, 1987

Related Questions

What is the starting dose of lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) for patients with hypertension or heart failure?
What is the recommended dosing for lisinopril (Angiotensin-Converting Enzyme inhibitor) in patients with hypertension or heart failure?
What is the next step in managing a patient with uncontrolled hypertension on Lisinopril (angiotensin-converting enzyme inhibitor) 10 mg once daily with blood pressure readings in the range of 140-160 mmHg?
What is the recommended dosing of lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) for adults with hypertension, heart failure, or impaired renal function?
What is the appropriate dosing of lisinopril (angiotensin-converting enzyme inhibitor) for a patient with hypertension, considering potential impaired renal function and other comorbidities?
What are the Nexus low risk criteria (Nexus low risk criteria) for evaluating cervical spine injury in trauma patients?
What is the cause of dengue fever, particularly in individuals who have recently traveled to or reside in tropical and subtropical regions?
What type of arthritis presents with morning joint stiffness that improves with walking, such as osteoarthritis (OA) versus rheumatoid arthritis (RA)?
What are the recommended medications and treatment options for a patient with restless legs syndrome (RLS)?
What is a suitable intravenous (IV) antifungal agent for a patient with a positive urine culture for Candida glabrata?
What is the maximum safe rate of potassium infusion via a central line in a critically ill patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.